首页> 外文期刊>Heart >Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis
【24h】

Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis

机译:一大群严重主动脉瓣狭窄的老年患者行单纯主动脉瓣置换术后永久性起搏器植入

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives To assess the incidence of conduction disturbances leading to permanent pacemaker implantation (PPI) following isolated aortic valve replacement (AVR) in a large cohort of elderly patients with severe symptomatic aortic stenosis, and to determine the predictive factors and prognostic value of PPI following AVR in such patients. Methods A total of 780 consecutive elderly patients (age 77±4 years, logistic EuroSCORE 10.4±8.5%, STS score 3.5±1.5%) with severe aortic stenosis and no previous pacemaker were analysed. Main outcome measures The incidence, clinical indications, timing and predictive factors of PPI within 30 days after AVR and their prognostic value were evaluated. Results Baseline ECG showed the presence of conduction abnormalities in 37.1% of the patients. Twenty-five patients (3.2%) needed PPI during the index hospitalisation due to the occurrence of complete atrioventricular block (2.6%) or severe bradycardia (0.6%). The presence of preprocedural left bundle branch block (OR 4.65, 95% Cl 1.62 to 13.36, p=0.004) or right bundle branch block (OR 4.21, 95% Cl 1.47 to 12.03, p=0.007) predicted the need for PPI after AVR. The need for PPI was associated with a longer hospital stay (p<0.0001). Thirty-day mortality rates were similar between patients with and without PPI (4% vs 3.2%, p=0.56). Survival rate at 5-year follow-up was 75%, with no differences between patients with and without PPI (p=0.12). Conclusions The need for PPI following isolated AVR in elderly patients with severe symptomatic aortic stenosis was low. Pre-existing bundle branch block predicted the need for PPI. PPI determined a longer hospital stay, but had no effect on acute and long-term mortality.
机译:目的评估一大批严重症状性主动脉瓣狭窄老年患者中孤立主动脉瓣置换(AVR)后导致永久性起搏器植入(PPI)的传导障碍的发生率,并确定AVR后PPI的预测因素和预后价值在这样的病人中。方法回顾性分析780例重度主动脉瓣狭窄且既往没有起搏器的老年患者(年龄77±4岁,逻辑EuroSCORE 10.4±8.5%,STS​​评分3.5±1.5%)。主要预后指标评价AVR后30天内PPI的发生率,临床指征,时间和预测因素及其预后价值。结果基线心电图显示37.1%的患者存在传导异常。 25名患者(3.2%)因发生完全房室传导阻滞(2.6%)或严重心动过缓(0.6%)而在指数住院期间需要PPI。术前左束支传导阻滞(OR 4.65,95%Cl 1.62至13.36,p = 0.004)或右束支阻滞(OR 4.21,95%Cl 1.47至12.03,p = 0.007)预测AVR后需要PPI 。对PPI的需求与住院时间较长有关(p <0.0001)。有和没有PPI的患者的30天死亡率相似(4%比3.2%,p = 0.56)。 5年随访时的生存率为75%,有无PPI的患者之间无差异(p = 0.12)。结论老年严重症状性主动脉瓣狭窄患者单独进行AVR后对PPI的需求较低。预先存在的束支传导阻滞预测了对PPI的需求。 PPI确定住院时间更长,但对急性和长期死亡率没有影响。

著录项

  • 来源
    《Heart》 |2011年第20期|p.1687-1694|共8页
  • 作者单位

    Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada;

    Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada,Quebec Heart and Lung Institute, Laval University, 2725 Chemin Sainte-Foy, Quebec G1V 4G5, Canada;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号